Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.34 |
| ▸ | BACE1 | P56817 | 7/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22871815 | 0.85 | CYP19A1 (0.49) | CYP19A1PDK2BACE1EGLN1CYP11B1 | |
| SCHEMBL20230702 | 0.82 | CYP19A1 (0.45) | CYP19A1PDK2BACE1PIM1PIM2 | |
| SCHEMBL13231558 | 0.80 | HTR2A (0.41) | EGLN1PIM1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL17804309 | 0.80 | MEN1 (0.37) | CYP19A1BACE1EGLN1MEN1MAPT | |
| SCHEMBL15084750 | 0.79 | PDK2 (0.40) | CYP19A1PDK2BACE1EGLN1CYP11B1 | |
| SCHEMBL20230684 | 0.77 | CYP19A1 (0.40) | CYP19A1PDK2BACE1EGLN1CYP1A2 | |
| SCHEMBL21973898 | 0.77 | CYP19A1 (0.54) | CYP19A1PDK2EGLN1CYP11B1CYP11B2 | |
| SCHEMBL21510469 | 0.77 | CYP19A1 (0.48) | CYP19A1PDK2BACE1EGLN1CYP11B1 | |
| SCHEMBL20230706 | 0.77 | CYP19A1 (0.41) | CYP19A1PDK2BACE1PIM1PIM2 | |
| SCHEMBL15084800 | 0.76 | KMT2A (0.38) | CYP19A1PDK2EGLN1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180159050-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-06-07 | — | — | US | disclosed |
| US-20180159050-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180159050-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNE2, CCNT1 | CYP19A1 305/4885PDK2 1964/4885BACE1 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.